Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias

被引:11
作者
Da, DZ [1 ]
Yu, F [1 ]
机构
[1] China Pharmaceut Univ, Res Div Pharmacol, Nanjing 210009, Peoples R China
关键词
ion channels; arrhythmia; ryanodine receptor calcium release channel; FKBP12.6; sarcoplasmic reticulum; phospholamban; phosphorylation;
D O I
10.1111/j.1745-7254.2005.00134.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The occurrence of cardiac arrhythmias is related to the abnormality of ion channels not only in sarcolemma but also in the sarcoplasmic reticulum, which regulates the process of calcium release and up-take intracellularly. Patterns of ion channelopathy in the sarcolemma can be divided into single channel disorder from gene mutations and multiple channels disorder in a diseased hypertrophied heart. Abnormal RyR2, FKBP12.6, SERCA2a, and PLB are also involved in the initiation of cardiac arrhythmias. Maladjustment by hyperphosphorylation on the ion channels in the sarcolemma and RyR2-FKBP12.6 and SERCA2a-PLB is discussed. Hyperphosphorylation, which is the main abnormality upstream to ion channels, can be targeted for suppressing the deterioration of ion channelopathy in terms of new drug discovery in the treatment and prevention of malignant cardiac arrhythmias.
引用
收藏
页码:918 / 925
页数:8
相关论文
共 50 条
[21]   Molecular mechanisms underlying the long QT syndrome [J].
Dumaine, R ;
Antzelevitch, C .
CURRENT OPINION IN CARDIOLOGY, 2002, 17 (01) :36-42
[22]   USE-DEPENDENT EFFECTS OF THE CLASS-III ANTIARRHYTHMIC AGENT NE-10064 (AZIMILIDE) ON CARDIAC REPOLARIZATION - BLOCK OF DELAYED RECTIFIER POTASSIUM AND L-TYPE CALCIUM CURRENTS [J].
FERMINI, B ;
JURKIEWICZ, NK ;
JOW, B ;
GUINOSSO, PJ ;
BASKIN, EP ;
LYNCH, JJ ;
SALATA, JJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) :259-271
[23]   Is there a future for antiarrhythmic drug therapy? [J].
Guerra, PG ;
Talajic, M ;
Roy, D ;
Dubuc, M ;
Thibault, B ;
Nattel, S .
DRUGS, 1998, 56 (05) :767-781
[24]  
GUILLERMO TA, 2001, CIRCULATION, V103, P973
[25]   PREVENTION OF CLASS III-INDUCED PROARRHYTHMIAS BY FLECAINIDE IN AN ANIMAL-MODEL OF THE ACQUIRED LONG QT SYNDROME [J].
HALLMAN, K ;
CARLSSON, L .
PHARMACOLOGY & TOXICOLOGY, 1995, 77 (04) :250-254
[26]   Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells [J].
Han, W ;
Wang, ZG ;
Nattel, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (03) :H1075-H1080
[27]  
HORT BD, 1999, J MOL CELL CARDIOL, V31, P2007
[28]   Ibutilide: An antiarrhythmic agent for the treatment of atrial fibrillation or flutter [J].
Howard, PA .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (01) :38-47
[29]   RYR2 and CASQ2 mutations in patients suffering from catecholaminergic polymorphic ventricular tachycardia [J].
Lahat, H ;
Pras, E ;
Eldar, M .
CIRCULATION, 2003, 107 (03) :E29-E29
[30]   Reduction in QT dispersion and ventricular arrhythmias by ischaemic preconditioning in anaesthetized, normotensive and spontaneously hypertensive rats [J].
Lu, HR ;
Yu, F ;
Dai, DZ ;
Remeysen, P ;
De Clerck, F .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (04) :445-454